Quantcast

Latest Diagnostic tests Stories

2011-06-06 15:02:00

QUEBEC CITY, June 6, 2011 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter of fiscal 2011. The Company announced a net loss of $1,601,439 or $0.04 per share for the quarter ended April 30, 2011. These results reflect activities undertaken during this quarter and the Company's on-going commitment to develop...

2011-06-01 20:30:00

BEIJING, June 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, announced its unaudited financial results for the fourth fiscal quarter ("4Q FY2010") and the full fiscal year ended March 31, 2011 ("FY2010") today. 4Q FY2010 Highlights For the Three Months Ended --------------------------...

2011-03-31 07:00:00

HAYWARD, Calif. and MUNICH, March 31, 2011 /PRNewswire/ -- Advanced Cell Diagnostics (ACD), a technological leader in molecular pathology, and Definiens, a leading provider for biomedical image and data analysis, announce today a strategic partnership to develop image analysis applications that will enable researchers to accurately quantify specific RNA molecules within individual cells in routine clinical specimen. The partnership will build on ACD's RNAscope platform and add new...

2011-03-11 05:00:00

QUEBEC CITY, March 11 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011. The Company announced a net loss of $1,608,543 or $0.04 per share for the quarter ended January 31, 2011. These results reflect activities undertaken during this quarter and the Company's on-going commitment to...

2011-02-24 05:00:00

MADISON, N.J., Feb. 24, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has signed a definitive agreement to acquire Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific (NYSE: TMO) for $740 million in cash. Athena Diagnostics is the leading provider of advanced diagnostic tests used to rule...

2011-02-05 00:00:43

BioDot, the leading supplier of system tools for the research, development, and commercialization of diagnostic tests has completed its Wholly Owned Subsidiary certification and has opened an office in Shanghai, China. Irvine, CA (PRWEB) February 4, 2011 BioDot, the leading supplier of system tools for the research, development, and commercialization of diagnostic tests has completed its Wholly Owned Subsidiary certification and has opened an office in Shanghai, China. The new entity will...

2011-02-03 00:00:43

BioDot, the leading supplier of system tools for the research, development, and commercialization of diagnostic tests is relocating to a larger facility in Irvine, CA. The new facility has approximate 24,000 sq. ft. Irvine, CA (PRWEB) February 2, 2011 The new facility has approximate 24,000 sq. ft. In addition, the new facility will also allow us to have a larger application lab to continue to work with our customers as well as host our ongoing "hands on" workshops in house. On February 4,...

2011-01-19 15:05:00

- Agreement on a shareholder rights plan - QUEBEC CITY, Jan. 19 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering lab services, today reported financial and operation results for the fourth quarter 2010 and fiscal year ended October 31, 2010. The Company announced a net loss of $1,141,903 or $0.03 per share for the fourth quarter ending October 31, 2010, and a net loss of $8,817,417 or $0.21...

2010-12-10 17:30:00

SAN DIEGO, Dec. 10, 2010 /PRNewswire/ -- bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today new findings from a clinical study evaluating the company's Breast Cancer Index( )(BCI) molecular oncology test. Data from the study were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). The company also announced that the Breast Cancer Index is now available to...

2010-11-11 14:39:28

Discovery may guide treatment for acute myeloid leukemia Decoding the DNA of a woman who died of acute myeloid leukemia (AML) has led researchers at Washington University School of Medicine in St. Louis to a gene that they found to be commonly altered in many patients who died quickly of the disease. The findings, if confirmed in larger studies, suggest that a diagnostic test for mutations in the gene could identify AML patients who need more aggressive treatment right from the start. The new...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.